| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
psoriasis susceptibility 9 | 1.000 | 0.038 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2006 | 2014 | |||||||||
|
psoriasis susceptibility 6 | 0.931 | 0.038 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2003 | 2015 | |||||||||
|
psoriasis susceptibility 5 | 0.931 | 0.038 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2011 | |||||||||
|
late cornified envelope 3D | 0.890 | 0.038 | 2.1E-02 |
|
disease | 0.310 | None | 1.000 | 3 | 0 | 2010 | 2014 | ||||||||
|
ZNF816-ZNF321P readthrough | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2015 | |||||||||
|
long intergenic non-protein coding RNA 1714 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2015 | |||||||||
|
ubiquitin B pseudogene 4 | 1.000 | 0.038 | 3.6E-06 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2015 | ||||||||
|
microRNA 320b-1 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
ELOA antisense RNA 1 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
microRNA 6731 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1932 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
psoriasis susceptibility 8 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
ring finger protein 145 | 1.000 | 0.038 | 0.98 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
leucine rich repeat containing 43 | 0.931 | 0.038 | 4.7E-15 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
PNN interacting serine and arginine rich protein | 1.000 | 0.038 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
T cell activation inhibitor, mitochondrial | 1.000 | 0.038 | 2.2E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
T cell receptor alpha joining 23 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 2693 | 1.000 | 0.038 | 0.11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
chromosome 10 open reading frame 99 | 0.931 | 0.038 | 0.21 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
secreted LY6/PLAUR domain containing 2 | 0.931 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
uncharacterized protein PRO2268 | 0.931 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
msh homeobox 2 pseudogene 1 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
proline rich 9 | 1.000 | 0.038 | 3.2E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
psoriasis susceptibility 7 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
T cell receptor gamma variable 5 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |